|
|
 |
|
Viewing report
|
|
|
|
China Diabetes Care Devices Investment opportunities Analysis and Forecasts to 2012
Global Markets Direct, Aug 2008, Pages: 70
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
3 Definitions of Markets Covered in the Report
3.1 Diabetes Care Devices
3.2 Glucose Monitoring
3.2.1 Blood Glucose Meter
3.2.2 Blood Glucose Strips
3.3 Insulin Delivery
3.3.1 Insulin Jet Injector
3.3.2 Insulin Pen
3.3.3 Insulin Pump
3.3.4 Insulin Syringes
4 Healthcare Sector Review
4.1 Healthcare Expenditure
4.2 Healthcare Infrastructure
4.2.1 Healthcare Personnel Data
4.2.2 Healthcare Facilities Data
4.3 Healthcare Policy
4.4 China Healthcare Trade Statistics
5 Regulation System
5.1 Medical Equipment Approval Process
5.1.1 Classification
5.1.2 Registration and Conformity assessment
5.1.3 China Compulsory Certificate (CCC Mark)
5.1.4 Labeling and Packaging
5.1.5 Registration Fee
5.1.6 Registration Period
5.2 Post Market Surveillance (PMS)
6 Pricing and Reimbursement
7 Distribution Structure
8 China Cross Market Comparison
9 Diabetes Care Devices Cross Country Comparison
10 Diabetes Care Devices in China
10.1 Diabetes Care Devices Overall Revenues by Category (2000-2012)
10.2 Diabetes Care Devices Overall Volume by Category (2000-2012)
10.3 Diabetes Care Devices Overall Company Share (2006-2007)
11 Glucose Monitoring in China
11.1 Glucose Monitoring Revenues by Segment (2000-2012)
11.2 Glucose Monitoring Volume by Segment (2000-2012)
11.3 Glucose Monitoring Average Price (2000-2012)
11.4 Glucose Monitoring Distribution Share (2006-2007)
11.5 Glucose Monitoring Company Share (2006-2007)
12 Insulin Delivery in China
12.1 Insulin Delivery Revenues by Segment (2000-2012)
12.2 Insulin Delivery Volume by Segment (2000-2012)
12.3 Insulin Delivery Average Price (2000-2012)
12.4 Insulin Delivery Distribution Share (2006-2007)
12.5 Insulin Delivery Company Share (2006-2007)
13 F. Hoffmann-La Roche Ltd. Company Profile
13.1 Company Overview
13.2 Value Chain Analysis
13.2.1 Manufacturing
13.2.2 Product Development
13.2.3 Sales and Marketing
14 Abbott Laboratories Strategic Analysis Profile
14.1 Company Overview
14.2 Value Chain Analysis
14.2.1 Manufacturing
14.2.2 Product Development
14.2.3 Sales and Marketing
14.3 Abbott Laboratories Pipeline Products
14.3.1 Abbott Laboratories Pipeline Products By Equipment Type
14.3.2 Abbott Laboratories Pipeline Products By Development Stage
14.3.3 Abbott Laboratories Pipeline Products By Therapy Area
14.3.4 Abbott Laboratories Pipeline Products By Clinical Trials
14.3.5 Abbott Laboratories Pipeline Products By News Summary
15 LifeScan, Inc. Company Profile
15.1 Company Overview
15.2 LifeScan, Inc. Pipeline Products
15.2.1 LifeScan, Inc. Pipeline Products by Equipment Type
15.2.2 LifeScan, Inc. Pipeline Products by Development Stage
15.2.3 LifeScan, Inc. Pipeline Products by Therapy Area
15.2.4 LifeScan, Inc. Pipeline Products by News Summary
16 Novo Nordisk A/S Company Profile
16.1 Company Overview
16.2 Novo Nordisk A/S Pipeline Products
16.2.1 Novo Nordisk A/S Pipeline Products by Equipment Type
16.2.2 Novo Nordisk A/S Pipeline Products by Development Stage
16.2.3 Novo Nordisk A/S Pipeline Products by Therapy Area
17 Becton, Dickinson and Company Strategic Analysis Profile
17.1 Company Overview
17.2 Value Chain Analysis
17.2.1 Manufacturing
17.2.2 Product Development
17.2.3 Sales and Marketing
18 Appendix
18.1 Global Markets Direct Research Methodology
18.2 Coverage
18.3 Secondary Research
18.4 Primary Research
18.5 Models
18.6 Forecasts
18.7 Expert Panels
18.8 Currency Conversion
18.9 Contact Us
18.10 Disclaimer
List of Tables
Table 1: Doctors by Specialty in China, 2003-2007
Table 2: Hospital Wards by Specialty in China, 2003 - 2007
Table 3: Healthcare Institutions in China, 2000-2004
Table 4: Personnel Employed in Healthcare Institutions in China, 2000-2004
Table 5: Healthcare Institutions, Hospital Beds and Employed Personnel by Region in China, 2004
Table 6: China Healthcare Trade Statistics, 2001-2006
Table 7: China, Medical Equipment Market Comparison
Table 8: Diabetes Care Devices Market, Country Comparison
Table 9: Diabetes Care Devices, China, Category Revenues ($ mn), 2000-2012
Table 10: Diabetes Care Devices Market, China, Portfolio Analysis
Table 11: Diabetes Care Devices, China, Category Revenues ($ mn), Historic, 2000-2007
Table 12: Diabetes Care Devices, China, Category Revenues ($ mn), Forecast, 2007-2012
Table 13: Diabetes Care Devices, China, Overall Volume (Units), 2000-2012
Table 14: Diabetes Care Devices, China, Overall Volume (Units), Historic, 2000-2007
Table 15: Diabetes Care Devices, China, Overall Volume (Units), Forecast, 2007-2012
Table 16: Diabetes Care Devices, China, Overall Company Share by Revenue ($ mn), 2006-2007
Table 17: Glucose Monitoring, China, Revenue ($ mn) by Segment, Historic, 2000-2007
Table 18: Glucose Monitoring, China, Revenue ($ mn) by Segment, Forecast, 2007-2012
Table 19: Glucose Monitoring, China, Volume (Units) by Segment, Historic, 2000-2007
Table 20: Glucose Monitoring, China, Volume (Units) by Segment, Forecast, 2007-2012
Table 21: Glucose Monitoring, China, Average Price ($), Historic, 2000-2007
Table 22: Glucose Monitoring, China, Average Price ($), Forecast, 2007-2012
Table 23: Glucose Monitoring, China, Distribution Share by Revenue ($ mn), 2006-2007
Table 24: Glucose Monitoring, China, Company Share by Revenue ($ mn), 2006-2007
Table 25: Insulin Delivery, China, Revenue ($ mn) by Segment, Historic, 2000-2007
Table 26: Insulin Delivery, China, Revenue ($ mn) by Segment, Forecast, 2007-2012
Table 27: Insulin Delivery, China, Volume (Units) by Segment, Historic, 2000-2007
Table 28: Insulin Delivery, China, Volume (Units) by Segment, Forecast, 2007-2012
Table 29: Insulin Delivery, China, Average Price ($), Historic, 2000-2007
Table 30: Insulin Delivery, China, Average Price ($), Forecast, 2007-2012
Table 31: Insulin Delivery, China, Distribution Share by Revenue ($ mn), 2006-2007
Table 32: Insulin Delivery, China, Company Share by Revenue ($ mn), 2006-2007
Table 33: Abbott Laboratories Pipeline Products by Equipment Type
Table 34: Abbott Laboratories Pipeline Products By Development Stage
Table 35: Abbott Laboratories Pipeline Products By Therapy Area
Table 36: Abbott Laboratories Pipeline Products By Clinical Trials
Table 37: Abbott Laboratories Pipeline Products By News Summaries
Table 38: LifeScan, Inc. Pipeline Products by Equipment Type
Table 39: LifeScan, Inc. Pipeline Products By Development Stage
Table 40: LifeScan, Inc. Pipeline Products By Therapy Area
Table 41: LifeScan, Inc. Pipeline Products By News Summaries
Table 42: Novo Nordisk A/S Pipeline Products by Equipment Type
Table 43: Novo Nordisk A/S Pipeline Products By Development Stage
Table 44: Novo Nordisk A/S Pipeline Products By Therapy Area
Table 45: Currency Conversion from USD to Local Currency at 2007 Constant Rate
List of Figures
Figure 1: Total Healthcare Expenditure in China, 2000 – 2005
Figure 2: Medical Equipment Registration Process in China, 2007
Figure 3: CCC Mark Certification Process in China, 2007
Figure 4: China, Medical Equipment Market Comparison, 2007
Figure 5: Diabetes Care Devices, Revenues ($ mn) by Country, 2000-2012
Figure 6: Diabetes Care Devices Market, Country Comparison
Figure 7: Diabetes Care Devices, China, Category Revenues ($ mn), 2000-2012
Figure 8: Diabetes Care Devices Market, China, Portfolio Analysis
Figure 9: Diabetes Care Devices, China, Category Revenues ($ mn), Historic, 2000-2007
Figure 10: Diabetes Care Devices, China, Category Revenues ($ mn), Forecast, 2007-2012
Figure 11: Diabetes Care Devices, China, Overall Company Share (%), 2007
Figure 12: Glucose Monitoring, China, Revenue ($ mn) by Segment, Historic, 2000-2007
Figure 13: Glucose Monitoring, China, Revenue ($ mn) by Segment, Forecast, 2007-2012
Figure 14: Glucose Monitoring, China, Volume (Units) by Segment, Historic, 2000-2007
Figure 15: Glucose Monitoring, China, Volume (Units) by Segment, Forecast, 2007-2012
Figure 16: Glucose Monitoring, China, Company Share (%), 2007
Figure 17: Insulin Delivery, China, Revenue ($ mn) by Segment, Historic, 2000-2007
Figure 18: Insulin Delivery, China, Revenue ($ mn) by Segment, Forecast, 2007-2012
Figure 19: Insulin Delivery, China, Company Share (%), 2007
Figure 20: F. Hoffmann-La Roche Ltd., Value Chain Analysis
Figure 21: Abbott Laboratories, Value Chain Analysis
Figure 22: Becton, Dickinson and Company, Value Chain Analysis
Figure 23: Global Markets Direct Methodology
Customers who bought this item also bought
The 2009-2014 Outlook for Diabetes Monitoring Devices in Greater China
China Diabetes Care Devices Market Analysis & Forecasts to 2015
China Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2015
The 2007-2012 Outlook for Diabetes Monitoring Devices in Greater China
China Medical Equipment Market Analysis and Forecasts to 2015
China Anti-Diabetic Drug Market Report 2008
China Pharmaceuticals and Healthcare Report Q1 2008
Canada Diabetes Care Devices Market Analysis and Forecasts to 2015
UK Diabetes Care Devices Market Analysis and Forecasts to 2015
France Diabetes Care Devices Market Analysis and Forecasts to 2015
Italy Diabetes Care Devices Market Analysis and Forecasts to 2015
Spain Diabetes Care Devices Market Analysis and Forecasts to 2015
|
|
|
|
